Know-How Reduction. During the applicable Royalty Term and on a country-by-country and Pathogen Combination Product-by-Pathogen Combination Product basis, the royalty rate for a Pathogen Combination Product in a country shall be reduced by [*****] of the applicable rate determined pursuant to Section 8.3.1, if such Pathogen Combination Product is not or no longer Covered by a Valid Claim in such country. For clarity, this reduction shall not apply to the calculation of Net Sales for the purposes of the Net Profit split.
Appears in 4 contracts
Samples: Covid Cla Third Amendment and Restatement Agreement (CureVac N.V.), Covid Cla Amendment and Restatement Agreement (CureVac N.V.), Covid Collaboration and License Agreement
